Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.63 |
| ▸ | CA2 | P00918 | 3/20 | 0.63 |
| ▸ | CA9 | Q16790 | 3/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.63 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | CA5A | P35218 | 1/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.63 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.63 |
| ▸ | HSD17B1 | P14061 | 5/20 | 0.44 |
| ▸ | HSD17B2 | P37059 | 4/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | ACHE | P22303 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | LCK | P06239 | 1/20 | 0.43 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Resorcinol SCHEMBL1243197 | 1.00 | CA12 (0.63) | CA12ALDH1A1CA2CA9CYP3A4 | |
| Resorcinol SCHEMBL4211332 | 1.00 | CA12 (0.63) | CA12ALDH1A1CA2CA9CYP3A4 | |
| Phloroglucinol SCHEMBL29110699 | 0.86 | BACE1 (0.50) | CA12ALDH1A1CA2CA9CYP3A4 | |
| Resorcinol SCHEMBL7559136 | 0.82 | TSHR (0.46) | CA12ALDH1A1CA2CA9CYP3A4 | |
| Resorcinol SCHEMBL7561949 | 0.82 | TSHR (0.46) | CA12ALDH1A1CA2CA9CYP3A4 | |
| Phenol SCHEMBL5509919 | 0.81 | CA12 (0.61) | CA12ALDH1A1CA2CA9CYP3A4 | |
| Phenol SCHEMBL27969880 | 0.81 | CA12 (0.61) | CA12ALDH1A1CA2CA9CYP3A4 | |
| Phenol SCHEMBL723357 | 0.81 | CA12 (0.61) | CA12ALDH1A1CA2CA9CYP3A4 | |
| Resorcinol SCHEMBL326229 | 0.80 | CA12 (1.00) | CA12ALDH1A1CA2CA9CYP3A4 | |
| Resorcinol SCHEMBL15515 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116512724-A | Surface film for composite laminates | 罗尔公司 | 2023-08-01 | — | — | CN | claimed |
| EP-2835368-B1 | Process for Isolation of Monophenolic-Bisaryl Triazines | CYTEC TECH CORP (US) | 2017-11-15 | — | — | EP | claimed |
| EP-2289884-B1 | Process for isolation of monophenolic bisaryl triazines | CYTEC TECH CORP (US) | 2017-09-06 | — | — | EP | claimed |
| CN-106990606-A | Liquid crystal display including quantum dot film and color purity enhanced film | 爱思开哈斯显示用薄膜有限公司 | 2017-07-28 | — | — | CN | claimed |
| EP-1397352-B1 | PROCESS FOR ISOLATION OF MONOPHENOLIC-BISARYL TRIAZINES | CYTEC TECH CORP (US) | 2014-01-01 | — | — | EP | claimed |
| CN-118265762-A | Electrochromic gel and device comprising same | PPG工业俄亥俄公司 | 2024-06-28 | — | — | CN | disclosed |
| EP-4355830-A1 | COATING COMPOSITIONS, METHODS OF MAKING AND USING SAME | Perfect Carbon LLC (US) | 2024-04-24 | — | — | EP | disclosed |
| CN-116512724-A | Surface film for composite laminates | 罗尔公司 | 2023-08-01 | — | — | CN | disclosed |
| WO-2022266545-A1 | COATING COMPOSITIONS, METHODS OF MAKING AND USING SAME | PERFECT CARBON LLC (US) | 2022-12-22 | — | — | WO | disclosed |
| CN-106488762-B | Sunscreen with visual shading of excessive whiteness due to titanium dioxide and zinc oxide upon skin application | 株式会社资生堂 | 2018-04-06 | — | — | CN | disclosed |
| EP-2835368-B1 | Process for Isolation of Monophenolic-Bisaryl Triazines | CYTEC TECH CORP (US) | 2017-11-15 | — | — | EP | disclosed |
| EP-2289884-B1 | Process for isolation of monophenolic bisaryl triazines | CYTEC TECH CORP (US) | 2017-09-06 | — | — | EP | disclosed |
| US-20020161232-A1 | Use of aromatic compounds as phase directors and particle size reducers for quinacridone pigments | CIBA SPECIALTY CHEMICALS CORP. | 2002-10-31 | — | — | US | disclosed |
| US-20020161232-A1 | Use of aromatic compounds as phase directors and particle size reducers for quinacridone pigments | CIBA SPECIALTY CHEMICALS CORP. | 2002-10-31 | — | — | US | disclosed |
| WO-2002077104-A1 | THE USE OF AROMATIC COMPOUNDS AS PHASE DIRECTORS AND PARTICLE SIZE REDUCERS FOR QUINACRIDONE PIGMENTS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-10-03 | — | — | WO | disclosed |
| WO-2002077104-A1 | THE USE OF AROMATIC COMPOUNDS AS PHASE DIRECTORS AND PARTICLE SIZE REDUCERS FOR QUINACRIDONE PIGMENTS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-10-03 | — | — | WO | disclosed |
| US-6239275-B1 | Trisaryl-1,3,5-triazine ultraviolet light absorbers containing hindered phenols | CIBA SPECIALTY CHEMICALS CORPORATION | 2001-05-29 | — | — | US | disclosed |
| US-6225468-B1 | HEATING AND PRESSURIZING TRIHALO-1,3,5-TRIAZINE WITH PHENOL DERIVATIVE AND BENZENE DERIVATIVE TO IN PRESENCE OF CATALYST FORM ARYL SUBSTITUTED TRIAZINE COMPOUND | CYTEC TECHNOLOGY CORP. | 2001-05-01 | — | — | US | disclosed |
| EP-1087947-A2 | TRISARYL-1,3,5-TRIAZINE ULTRAVIOLET LIGHT ABSORBERS CONTAINING HINDERED PHENOLS | Ciba SC Holding AG (CH) | 2001-04-04 | — | — | EP | disclosed |
| WO-1999067223-A2 | TRISARYL-1,3,5-TRIAZINE ULTRAVIOLET LIGHT ABSORBERS CONTAINING HINDERED PHENOLS | CYTEC TECH CORP (US) | 1999-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020161232-A1 | Use of aromatic compounds as phase directors and particle size reducers for quinacridone pigments | QDPR, POLR2H, POLR2E | CA12 3416/4885ALDH1A1 377/4885CA2 3345/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.